The World Health Organization (WHO) welcomed Canada’s recent tabling of new legislation which, if passed, would allow drug manufacturers to export low-cost, quality medicines to the world’s poorest countries.
Canada is the first country to propose changes to its patent legislation to put into practice a decision made by World Trade Organization (WTO) members on 30 August 2003, which allows exports of generic medicines to countries with insufficient pharmaceutical manufacturing.
The original intention of the WTO agreement was to facilitate the supply of affordable generic drugs for developing countries. See related EPHA articles.
All WHO Press Releases, Fact Sheets and Features can be obtained on the WHO home page
